Merck KGaA (MRK) PT Set at €115.00 by Kepler Capital Markets
Merck KGaA (FRA:MRK) received a €115.00 ($135.29) price target from investment analysts at Kepler Capital Markets in a research note issued to investors on Wednesday. The brokerage presently has a “buy” rating on the healthcare company’s stock.
MRK has been the subject of several other research reports. Goldman Sachs Group, Inc. (The) set a €105.00 ($123.53) target price on shares of Merck KGaA and gave the company a “neutral” rating in a research note on Tuesday, September 19th. Citigroup Inc. set a €123.00 ($144.71) price target on shares of Merck KGaA and gave the stock a “buy” rating in a research report on Monday, September 25th. DZ Bank AG reissued a “sell” rating on shares of Merck KGaA in a research report on Tuesday, July 18th. Warburg Research set a €116.00 ($136.47) price target on shares of Merck KGaA and gave the company a “neutral” rating in a report on Friday, July 7th. Finally, Commerzbank Ag set a €109.00 ($128.24) price target on shares of Merck KGaA and gave the company a “neutral” rating in a report on Wednesday, September 6th. Thirteen analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of €109.43 ($128.75).
Shares of Merck KGaA (MRK) opened at 96.52 on Wednesday. The firm has a market capitalization of €41.96 billion and a price-to-earnings ratio of 25.16. The stock’s 50 day moving average price is €94.77 and its 200-day moving average price is €101.91. Merck KGaA has a 12 month low of €89.00 and a 12 month high of €115.00.
Merck KGaA Company Profile
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.